Fulltext

Sequential intravenous-oral amoxycillin/clavulanate (Augmentin) therapy in paediatric hospital practice

Schaad, Urs B. ; Pfenninger, Jürg ; Wedgwood-Krucko, Joanna

In: Journal of Antimicrobial Chemotherapy, 1987, vol. 19, no. 3, p. 385-391

Add to personal list
    Title
    • Sequential intravenous-oral amoxycillin/clavulanate (Augmentin) therapy in paediatric hospital practice
    Author
    • Schaad, Urs B.. Division of Paediatric Infectious Diseases and Intensive Care Unit, Department of Paediatrics, University of Berne, Inselspital, CH-3010 Berne, Switzerland
    • Pfenninger, Jürg. Division of Paediatric Infectious Diseases and Intensive Care Unit, Department of Paediatrics, University of Berne, Inselspital, CH-3010 Berne, Switzerland
    • Wedgwood-Krucko, Joanna. Division of Paediatric Infectious Diseases and Intensive Care Unit, Department of Paediatrics, University of Berne, Inselspital, CH-3010 Berne, Switzerland
    Document Type
    • Postprint
    Language
    • English
    Published in
    • Journal of Antimicrobial Chemotherapy, 1987, vol. 19, no. 3, p. 385-391. Oxford University Press
    Other Version
    OAI-PMH Identifier
    • oai:doc.rero.ch:302318
    Summary
    The efficacy and safety of intravenous and sequential intravenous-oral clavulanate-potentiated amoxycillin therapy was evaluated in 71 hospitalized paediatric patients, one month to 16 years of age. The infections treated included peritonsillar abscess (2 patients), purulent tracheitis (1), acute epiglottitis (24), pneumonia (31), pansinusitis (4), mastoiditis (1), cellulitis (4), lymphadenitis (2) and pyelonephritis (2). The severity of disease was rated as moderate in 31 patients (44%), and as severe in 40 (56%). Bacterial pathogens could be cultured in 26 cases (37%). The response to therapy was prompt and followed by clinical cure in each patient. Adverse drug effects included phlebitis (in 6%), mild gastrointestinal complaints (6%), rash (4%) and transient neutropenia and elevation of transaminases (one case each). It is concluded that amoxycillin/clavulanate is effective and safe treatment for bacterial infections of the respiratory tract, urinary tract, skin or soft tissues in children